AβPP

ANTIBODY polyclonal manufacturer Cat# LS-C62326<br />manufacturer: LifeSpan Biosciences immunogen = APP antibody was raised against synthetic peptide, KLH conj. liquid, HEPES, BSA, glycerol, azide, purified AβPP IgG APP, APLP, AICD Autogen Bioclear Rabbit Hu

AβPP

ANTIBODY polyclonal manufacturer Cat# LS-B691<br /> Replaces Cat# LS-C19066<br />manufacturer: LifeSpan Biosciences immunogen = Beta amyloid peptide D-A-E-F-R-H-D-S-G-Y-E-V-H-H conjugated to KLH using maleimide. The sequence corresponds to aa 1-14 of h

Emmanuel Oc

No
Brown, Nigeria

Hollie Young

Lumberton, United States

PAPER Béné R, Antić S, Budisić M, Lisak M, Trkanjec Z, Demarin V, Podobnik-Sarkanji S

Parkinson's disease.

Acta Clin Croat. 2009 Sep;48(3):377-80. PubMed: 20055267

PAPER Duran R, Barrero FJ, Morales B, Luna JD, Ramirez M, Vives F

Plasma alpha-synuclein in patients with Parkinson's disease with and without treatment.

Mov Disord. 2010 Mar 15;25(4):489-93. PubMed: 20063406

PAPER Edwards TL, Scott WK, Almonte C, Burt A, Powell EH, Beecham GW, Wang L, Züchner S, Konidari I, Wang G, Singer C, Nahab F, Scott B, Stajich JM, Pericak-Vance M, Haines J, Vance JM, Martin ER

Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease.

Ann Hum Genet. 2010 Mar;74(2):97-109. PubMed: 20070850

PAPER Carballo-Carbajal I, Weber-Endress S, Rovelli G, Chan D, Wolozin B, Klein CL, Patenge N, Gasser T, Kahle PJ

Leucine-rich repeat kinase 2 induces alpha-synuclein expression via the extracellular signal-regulated kinase pathway.

Cell Signal. 2010 May;22(5):821-7. PubMed: 20074637

PAPER Graham DR, Sidhu A

Mice expressing the A53T mutant form of human alpha-synuclein exhibit hyperactivity and reduced anxiety-like behavior.

J Neurosci Res. 2010 Jun;88(8):1777-83. PubMed: 20077428

PAPER Eriksen J, Jørgensen TN, Gether U

Regulation of dopamine transporter function by protein-protein interactions: new discoveries and methodological challenges.

J Neurochem. 2010 Apr;113(1):27-41. PubMed: 20085610

PAPER Asikainen S, Rudgalvyte M, Heikkinen L, Louhiranta K, Lakso M, Wong G, Nass R

Global microRNA expression profiling of Caenorhabditis elegans Parkinson's disease models.

J Mol Neurosci. 2010 May;41(1):210-8. PubMed: 20091141

PAPER Pan-Montojo F, Anichtchik O, Dening Y, Knels L, Pursche S, Jung R, Jackson S, Gille G, Spillantini MG, Reichmann H, Funk RH

Progression of Parkinson's disease pathology is reproduced by intragastric administration of rotenone in mice.

PLoS One. 2010;5(1):e8762. PubMed: 20098733

PAPER Mitra T, Chaudhuri KR

Sleep dysfunction and role of dysautonomia in Parkinson's disease.

Parkinsonism Relat Disord. 2009 Dec;15 Suppl 3:S93-5. PubMed: 20083018

PAPER Tsukakoshi K, Harada R, Sode K, Ikebukuro K

Screening of DNA aptamer which binds to alpha-synuclein.

Biotechnol Lett. 2010 May;32(5):643-8. PubMed: 20111982

PAPER Dadakhujaev S, Noh HS, Jung EJ, Cha JY, Baek SM, Ha JH, Kim DR

Autophagy protects the rotenone-induced cell death in alpha-synuclein overexpressing SH-SY5Y cells.

Neurosci Lett. 2010 Mar 12;472(1):47-52. PubMed: 20117172